Lost in Translation: the Gap Between Neurobiological Mechanisms and Psychosocial Treatment Research for Substance Use Disorders

2021 ◽  
Author(s):  
Elizabeth D. Reese ◽  
Louisa F. Kane ◽  
Catherine E. Paquette ◽  
Flavio Frohlich ◽  
Stacey B. Daughters
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Psychosocial Treatment ◽  
Treatment Research ◽  
Lost In Translation

A unifying translational framework to advance treatment research for comorbid PTSD and substance use disorders

2021 ◽  
Author(s):  
Denise Hien ◽  
Teresa Lopez-Castro ◽  
Skye Fitzpatrick ◽  
Lesia M. Ruglass ◽  
Eric A. Fertuck ◽  
...  
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Treatment Research

Psychosocial Treatment Approaches for Substance Use

2018 ◽  
Author(s):  
Lynn McFarr ◽  
Julie Snyder ◽  
Lisa Benson ◽  
Rachel Higier
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Meta Analysis ◽  
Contingency Management ◽  
Psychosocial Interventions ◽  
Psychosocial Treatment ◽  
Community Based ◽  
Theoretical Orientations ◽  
Psychosocial Treatments ◽  
Community Based Programs

Multiple psychosocial treatments for substance-use disorders have been studied for efficacy. A recent meta-analysis indicates that psychosocial interventions are effective across multiple types of substances used. In the case of opiates, psychosocial interventions combined with medication appear to be the most effective. Many studies further agree that psychosocial interventions are an integral and necessary part of treating substance-use disorders. Although theoretical orientations may differ across psychosocial treatments, they have several principles and practices in common. All involve talk therapy or talk in communities as a way to clarify triggers, build commitment, and improve accountability. Many also target addiction behaviors and work to develop alternative contingencies to reduce or eliminate use. Finally, targeting repeated performance (or building “chains of committed behavior”) decreases the likelihood of relapse. This chapter discusses the most frequently studied and employed psychosocial treatments for substance use including CBT, motivational interviewing, contingency management, mindfulness, and community-based programs.

scholarly journals Web-based, psychosocial treatment for substance use disorders in community treatment settings.

2012 ◽  
Vol 9 (2) ◽  
pp. 212-214 ◽  
Author(s):  
Aimee N. C. Campbell ◽  
Gloria M. Miele ◽  
Edward V. Nunes ◽  
Scott McCrimmon ◽  
Udi E. Ghitza
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Psychosocial Treatment ◽  
Community Treatment ◽  
Web Based ◽  
Treatment Settings

Critical Care Medicine

2016 ◽  
pp. 719-728
Author(s):  
Cassie C. Kennedy
Keyword(s):  
Substance Use ◽  
Critical Care ◽  
Substance Use Disorders ◽  
Age Groups ◽  
Psychosocial Treatment ◽  
Racial Groups ◽  
Self Help ◽  
Self Help Groups ◽  
Alcohol And Other Drugs ◽  
Pharmacologic Agents

Alcohol and other substance use disorders are a major concern in all age groups and across all ethnic, socioeconomic, and racial groups. Despite high lifetime prevalence (up to 20%), less than 10% of persons with substance use disorders are involved in treatment (either self-help groups or professional care). Several pharmacologic agents are available to help diminish the craving for alcohol and other drugs or to deter relapse. Although several medications, including disulfiram, acamprosate, and naltrexone, may help prevent relapse, they are adjunctive and not a substitute for comprehensive psychosocial treatment.

scholarly journals Assessment and treatment of mood disorders in the context of substance abuse

2015 ◽  
Vol 17 (2) ◽  
pp. 181-190 ◽  
Keyword(s):  
Substance Abuse ◽  
Substance Use ◽  
Mood Disorders ◽  
Substance Use Disorders ◽  
Clinical Decision Making ◽  
Bipolar Disorders ◽  
Clinical Decision ◽  
Public Health Burden ◽  
Substance Dependent ◽  
Treatment Research

Recognition and management of mood symptoms in individuals using alcohol and/or other drugs represent a daily challenge for clinicians in both inpatient and outpatient treatment settings. Diagnosis of underlying mood disorders in the context of ongoing substance abuse requires careful collection of psychiatric history, and is often critical for optimal treatment planning and outcomes. Failure to recognize major depression or bipolar disorders in these patients can result in increased relapse rates, recurrence of mood episodes, and elevated risk of completed suicide. Over the past decade, epidemiologic research has clarified the prevalence of comorbid mood disorders in substance-dependent individuals, overturning previous assumptions that depression in these patients is simply an artifact of intoxication and/or withdrawal, therefore requiring no treatment. However, our understanding of the bidirectional relationships between mood and substance use disorders in terms of their course(s) of illness and prognoses remains limited. Like-wise, strikingly little treatment research exists to guide clinical decision making in co-occurring mood and substance use disorders, given their high prevalence and public health burden. Here we overview what is known and the salient gaps of knowledge where data might enhance diagnosis and treatment of these complicated patients.

Sign in / Sign up

Export Citation Format

Share Document